Sarda Proteins Ltd (BOM:519242)
India · Delayed Price · Currency is INR 97.78
0.00 (0.00%)
At close: Aug 3, 2026
Sarda Proteins Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 181.97 | 161.58 | 241.91 | 12.96 | 57.95 | 107.6 |
Other Revenue | - | - | 0 | - | - | - |
| 181.97 | 161.58 | 241.91 | 12.96 | 57.95 | 107.6 | |
Revenue Growth | -48.23% | -33.20% | 1766.88% | -77.64% | -46.14% | -5.28% |
Cost of Revenue | 138.96 | 154.78 | 239.11 | 12.07 | 57.18 | 102.86 |
Gross Profit | 43.01 | 6.8 | 2.8 | 0.89 | 0.77 | 4.73 |
Selling, General & Admin | 1.44 | 0.3 | 1 | 1.59 | 1.48 | 1.39 |
Other Operating Expenses | 66.41 | 3.6 | 1.61 | 0.76 | 0.77 | 0.64 |
Operating Expenses | 67.85 | 3.91 | 2.61 | 2.35 | 2.24 | 2.03 |
Operating Income | -24.84 | 2.9 | 0.2 | -1.46 | -1.47 | 2.7 |
Interest Expense | - | - | - | -0 | - | -0 |
Interest & Investment Income | - | - | 0.01 | 1.65 | 1.6 | 0.85 |
Other Non Operating Income (Expenses) | 58.29 | 3.48 | 0 | 0 | - | - |
EBT Excluding Unusual Items | 33.44 | 6.38 | 0.2 | 0.19 | 0.13 | 3.55 |
Other Unusual Items | - | - | - | - | - | -0.02 |
Pretax Income | 33.44 | 6.38 | 0.2 | 0.19 | 0.13 | 3.53 |
Income Tax Expense | 5.53 | - | 0.15 | -0.01 | 0.46 | 0.45 |
Net Income | 27.91 | 6.38 | 0.05 | 0.19 | -0.33 | 3.07 |
Net Income to Common | 27.91 | 6.38 | 0.05 | 0.19 | -0.33 | 3.07 |
Net Income Growth | - | 12407.84% | -73.71% | - | - | - |
Shares Outstanding (Basic) | 4 | 2 | 2 | 2 | 2 | 2 |
Shares Outstanding (Diluted) | 4 | 2 | 2 | 2 | 2 | 2 |
Shares Change | 108.47% | -0.11% | - | - | - | - |
EPS (Basic) | 7.89 | 3.70 | 0.03 | 0.11 | -0.19 | 1.78 |
EPS (Diluted) | 7.89 | 3.70 | 0.03 | 0.11 | -0.19 | 1.78 |
EPS Growth | - | 12421.57% | -73.14% | - | - | - |
Free Cash Flow | - | -763.89 | -1.11 | -2.31 | -3.01 | 1.04 |
Free Cash Flow Per Share | - | -443.07 | -0.64 | -1.34 | -1.75 | 0.60 |
Gross Margin | 23.63% | 4.21% | 1.16% | 6.84% | 1.34% | 4.40% |
Operating Margin | -13.65% | 1.79% | 0.08% | -11.30% | -2.54% | 2.51% |
Profit Margin | 15.34% | 3.95% | 0.02% | 1.50% | -0.57% | 2.86% |
Free Cash Flow Margin | - | -472.75% | -0.46% | -17.82% | -5.20% | 0.97% |
EBITDA | - | 2.9 | - | - | -1.46 | 2.7 |
EBITDA Margin | - | 1.80% | - | - | -2.53% | 2.51% |
D&A For EBITDA | - | 0.01 | - | - | 0 | 0 |
EBIT | -24.84 | 2.9 | 0.2 | -1.46 | -1.47 | 2.7 |
EBIT Margin | -13.65% | 1.79% | 0.08% | -11.30% | -2.53% | 2.51% |
Effective Tax Rate | 16.54% | - | 74.75% | - | 355.43% | 12.86% |
Revenue as Reported | 240.26 | 165.07 | 241.92 | 14.61 | 59.55 | 108.45 |
Advertising Expenses | - | - | 0.06 | 0.07 | 0.07 | 0.07 |